Company & Sponsor Intelligence
University Hospital, Geneva
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting2
Completed1
Countries1
Therapeutic footprint
depressionmovement_disordersother_neurologyparkinsons
Indexed studies
NCT05641441Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
other_neurology · SwitzerlandRECRUITING
other_neurology · SwitzerlandRECRUITING
NCT07531238Transcranial Temporal Interference Stimulation (tTIS) To Modulate Essential Tremor
movement_disorders · SwitzerlandNA
movement_disorders · SwitzerlandNA
NCT03076307DAT SPECT and Procedural Motor Skills in Parkinson's Disease
parkinsons · SwitzerlandNA
parkinsons · SwitzerlandNA
NCT06301282Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
parkinsons · SwitzerlandUNKNOWN
parkinsons · SwitzerlandUNKNOWN
NCT00944957Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz
depression · SwitzerlandNA
depression · SwitzerlandNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →